Literature DB >> 21286833

Mitogen-activated protein kinase p38 in HIV infection and associated brain injury.

Kathryn E Medders1, Marcus Kaul.   

Abstract

Infection with human immunodeficiency virus-1 (HIV-1) often leads to HIV-associated neurocognitive disorders (HAND) prior to the progression to acquired immunodeficiency syndrome (AIDS). At the cellular level, mitogen-activated protein kinases (MAPK) provide a family of signal transducers that regulate many processes in response to extracellular stimuli and environmental stress, such as viral infection. Recently, evidence has accumulated suggesting that p38 MAPK plays crucial roles in various pathological processes associated with HIV infection, ranging from macrophage activation to neurotoxicity and impairment of neurogenesis to lymphocyte apoptosis. Thus, p38 MAPK, which has generally been linked to stress-related signal transduction, may be an important mediator in the development of AIDS and HAND.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21286833      PMCID: PMC3690763          DOI: 10.1007/s11481-011-9260-0

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  153 in total

Review 1.  Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases.

Authors:  Puneet Chopra; Vijay Kanoje; Arvind Semwal; Abhijit Ray
Journal:  Expert Opin Investig Drugs       Date:  2008-10       Impact factor: 6.206

2.  Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy.

Authors:  S Koenig; H E Gendelman; J M Orenstein; M C Dal Canto; G H Pezeshkpour; M Yungbluth; F Janotta; A Aksamit; M A Martin; A S Fauci
Journal:  Science       Date:  1986-09-05       Impact factor: 47.728

3.  Bacteriologic and clinical evaluation of minocycline, a new tetracycline.

Authors:  R Cappel; J Klastersky
Journal:  Curr Ther Res Clin Exp       Date:  1971-04

4.  Molecular mechanism(s) involved in the synergistic induction of CXCL10 by human immunodeficiency virus type 1 Tat and interferon-gamma in macrophages.

Authors:  Navneet Dhillon; Xuhui Zhu; Fuwang Peng; Honghong Yao; Rachel Williams; Jianming Qiu; Shannon Callen; Amy O'Brien Ladner; Shilpa Buch
Journal:  J Neurovirol       Date:  2008-05       Impact factor: 2.643

Review 5.  Cellular reservoirs of HIV-1 and their role in viral persistence.

Authors:  Aikaterini Alexaki; Yujie Liu; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2008-09       Impact factor: 1.581

6.  Immunity and cognition: what do age-related dementia, HIV-dementia and 'chemo-brain' have in common?

Authors:  Jonathan Kipnis; Noel Christopher Derecki; Chunhui Yang; Heidi Scrable
Journal:  Trends Immunol       Date:  2008-09-11       Impact factor: 16.687

7.  HIV associated neurodegeneration requires p53 in neurons and microglia.

Authors:  Gwenn A Garden; Weiqun Guo; Suman Jayadev; Christina Tun; Stephanie Balcaitis; Jo Choi; Thomas J Montine; Thomas Möller; Richard S Morrison
Journal:  FASEB J       Date:  2004-05-20       Impact factor: 5.191

8.  HIV-1-infected and/or immune-activated macrophages regulate astrocyte CXCL8 production through IL-1beta and TNF-alpha: involvement of mitogen-activated protein kinases and protein kinase R.

Authors:  Jialin C Zheng; Yunlong Huang; Kang Tang; Min Cui; Doug Niemann; Alicia Lopez; Susan Morgello; Shengdi Chen
Journal:  J Neuroimmunol       Date:  2008-07-23       Impact factor: 3.478

9.  Involvement of the p53 and p73 transcription factors in neuroAIDS.

Authors:  Ruma Mukerjee; Satish L Deshmane; Shongshan Fan; Luis Del Valle; Martyn K White; Kamel Khalili; Shohreh Amini; Bassel E Sawaya
Journal:  Cell Cycle       Date:  2008-09-17       Impact factor: 4.534

10.  HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization.

Authors:  John P Norman; Seth W Perry; Holly M Reynolds; Michelle Kiebala; Karen L De Mesy Bentley; Margarita Trejo; David J Volsky; Sanjay B Maggirwar; Stephen Dewhurst; Eliezer Masliah; Harris A Gelbard
Journal:  PLoS One       Date:  2008-11-14       Impact factor: 3.240

View more
  16 in total

1.  Elevated brain monoamine oxidase activity in SIV- and HIV-associated neurological disease.

Authors:  Kelly A Meulendyke; Ceereena Ubaida-Mohien; Julia L Drewes; Zhaohao Liao; Lucio Gama; Kenneth W Witwer; David R Graham; M Christine Zink
Journal:  J Infect Dis       Date:  2014-03-31       Impact factor: 5.226

2.  Neuroprotective activity of pDING in response to HIV-1 Tat.

Authors:  Nune Darbinian; Kamel Khalili; Shohreh Amini
Journal:  J Cell Physiol       Date:  2014-02       Impact factor: 6.384

3.  Cell signaling pathways and HIV-1 therapeutics.

Authors:  Johnny J He
Journal:  J Neuroimmune Pharmacol       Date:  2011-03-30       Impact factor: 4.147

Review 4.  Type I Interferons in NeuroHIV.

Authors:  Victoria E Thaney; Marcus Kaul
Journal:  Viral Immunol       Date:  2018-09-27       Impact factor: 2.257

5.  Mass spectrometric phosphoproteome analysis of HIV-infected brain reveals novel phosphorylation sites and differential phosphorylation patterns.

Authors:  Lerna Uzasci; Sungyoung Auh; Robert J Cotter; Avindra Nath
Journal:  Proteomics Clin Appl       Date:  2015-08-12       Impact factor: 3.494

Review 6.  Of mice and monkeys: can animal models be utilized to study neurological consequences of pediatric HIV-1 infection?

Authors:  Heather Carryl; Melanie Swang; Jerome Lawrence; Kimberly Curtis; Herman Kamboj; Koen K A Van Rompay; Kristina De Paris; Mark W Burke
Journal:  ACS Chem Neurosci       Date:  2015-06-19       Impact factor: 4.418

Review 7.  Cell Signaling Pathways That Regulate Antigen Presentation.

Authors:  Randy R Brutkiewicz
Journal:  J Immunol       Date:  2016-10-15       Impact factor: 5.422

8.  Lipid rafts and functional caveolae regulate HIV-induced amyloid beta accumulation in brain endothelial cells.

Authors:  Ibolya E András; Sung Yong Eum; Michal Toborek
Journal:  Biochem Biophys Res Commun       Date:  2012-04-03       Impact factor: 3.575

Review 9.  Damage response involves mechanisms conserved across plants, animals and fungi.

Authors:  M A Hernández-Oñate; A Herrera-Estrella
Journal:  Curr Genet       Date:  2015-01-09       Impact factor: 3.886

Review 10.  Hyperphosphorylated tau is implicated in acquired epilepsy and neuropsychiatric comorbidities.

Authors:  Ping Zheng; Sandy R Shultz; Chris M Hovens; Dennis Velakoulis; Nigel C Jones; Terence J O'Brien
Journal:  Mol Neurobiol       Date:  2013-12-10       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.